Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1995-01-13
1998-05-19
Kight, John
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
534 14, 530311, A61K 5100, A61M 3614
Patent
active
057532052
ABSTRACT:
A diagnostic composition suitable for administration to a warm-blooded animal comprising somatostatin or a molecule capable of interacting with the somatostatin receptor labeled with a radionuclide by means of a chelate ligand capable of administration to an animal to produce reliable visual imaging of tumors or therapeutic effects on tumors.
REFERENCES:
patent: 4812554 (1989-03-01), Riggs
patent: 5225180 (1993-07-01), Dean et al.
patent: 5310536 (1994-05-01), Srinivasan
patent: 5371184 (1994-12-01), Rajagopalan et al.
patent: 5382654 (1995-01-01), Lyle et al.
patent: 5395946 (1995-03-01), Goedemans et al.
patent: 5405597 (1995-04-01), Dean et al.
patent: 5443815 (1995-08-01), Dean et al.
patent: 5443816 (1995-08-01), Zamora et al.
patent: 5460785 (1995-10-01), Rhodes et al.
Anderson et al (1992), J. Nucl. Med., vol. 33, pp. 1685-1691, "Cooper-64 Labeled Antibodies for PET Imaging".
Mathias et al (1990), Bioconjugate Chemistry, vol. 1, No. 3, pp. 204-211, "N,N'-bis(2-hydroxybenzyl)-1-(4-bromoacetamidobenzyl)-1,2-ethylene-diamine -N,N'-diacetic acid: A New Bifunctional Chelate for Radiolabeling Antibodies".
Anderson et al (1995), Journal of Nuclear Medicine, vol. 36, No. 12, pp. 2315-2325. "In Vitro and In Vivo Evaluation of Copper-64-Octreotide Conjugates".
Kwekkeboom et al., J. Nucl. Med., vol. 32, No. 5 (1991)
Albert et al., J. Nucl. Med., vol. 31 (1990) Abstract LMIO, "A Somatostatin Analogue to Image-S-S-Receptor-Positive Tumours . . . ".
Cox et al., Paper, 7th Int'l Symposium on Radiopharmacology (1991) "Technetium Labeled Somatostatin . . . " (Abstract).
Bakker et al., J. Nucl. Med., vol. 32, No. 6, pp. 1184-1188, (1991) "In Vivo Use of Radioiodinated Somatostatin Analogue".
Larson, J. Nucl. Med., vol. 32, No. 6, pp. 1189-1191, (1991) "Receptors on Tumors Studied . . . ".
Bakker, et al., J. Nucl. Med., vol. 31, No. 9, pp. 1501-1509, (1990) "Receptor Scintigraphy with a Radioiodinated Somatostatin Analogue".
Kwekkeboom, et al., J. Nucl. Med., vol. 32, No. 10, pp. 1845-1848 (1991) "Radioiodinated Somatostatin Analogue Scintigraphy".
Deutsch Karen
Lyle Leon R.
Rajagopalan Raghavan
Guffey Wendell Ray
Jones Dameron L.
Kight John
Mallinckrodt Medical Inc.
McBride Thomas P.
LandOfFree
Radiolabelled peptide compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabelled peptide compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabelled peptide compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1850208